Saito S, Nakazawa K, Nagahashi M, Ishikawa T, Akazawa K. Cost-effectiveness of BRCA1/2 mutation profiling to target olaparib use in patients with metastatic breast cancer. Personalized medicine. 2019. 16. 6. 439-448
Mitsuhiro Hayashi, Kyoko Nakazawa, Yoshie Hasegawa, Jun Horiguchi, Daishu Miura, Takashi Ishikawa, Shintaro Takao, Seung Jim Kim, Kazuhiko Yamagami, Masaru Miyashita, et al. Risk Analysis for Chemotherapy-induced Nausea and Vomiting (CINV) in Patients Receiving FEC100 Treatment. Anticancer research. 2019. 39. 8. 4305-4314